Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors

Autor: Christoph U. Correll, Marco Solmi, Giovanni Croatto, Lynne Kolton Schneider, S. Christy Rohani‐Montez, Leanne Fairley, Nathalie Smith, István Bitter, Philip Gorwood, Heidi Taipale, Jari Tiihonen

Publikováno v: World Psychiatry
World Psychiatry : official journal of the World Psychiatric Association
World Psychiatry : official journal of the World Psychiatric Association, Wiley Blackwell, 2022, 21 (2), pp.248-271. ⟨10.1002/wps.20994⟩

International audience; People with schizophrenia die 15-20 years prematurely. Understanding mortality risk and aggravating/attenuating factors is essential to reduce this gap. We conducted a systematic review and random-effects meta-analysis of pros

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a6adcfe6403351af23c6650e4f8de9
https://europepmc.org/articles/PMC9077617/

Capmatinib plus osimertinib versus platinum-pemetrexed doublet chemotherapy as second-line therapy in patients with stage IIIb/IIIc or IV EGFR-mutant, T790M-negative NSCLC harboring MET amplification

Autor: Yi-Long Wu, Ji-Youn Han, Terufumi Kato, Fabrice Barlesi, Edward B. Garon, Federico Cappuzzo, Yuji Shibata, Nathalie Smith, Sadhvi Khanna, Riccardo Belli, Alejandro Javier Yovine, Daniel S.W. Tan

Publikováno v: Journal of Clinical Oncology. 40:TPS9153-TPS9153

TPS9153 Background: MET amplification can arise as a bypass resistance mechanism to EGFR tyrosine kinase inhibitors (TKIs) and occurs in ̃5-26% of EGFR TKI resistant EGFR-mutant non-small cell lung cancer (NSCLC). These patients (pts) have limited t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::495136e0f475bedc403c3e69b0c2937b
https://doi.org/10.1200/jco.2022.40.16_suppl.tps9153